Method for the prediction of the likelihood of a major adverse coronary event (MACE) in a patient with acute coronary syndromes (ACS)

摘要

The present invention relates to a method for the prediction of the likelihood of a major adverse coronary event (MACE) in a patient with acute coronary syndromes (ACS), wherein the amount of vitronectin receptor gene product is determined in a s maple from a patient with acute coronary syndromes. Likewise the invention relates to the use of a kit for the prediction of the likelihood of a major adverse coronay event (MACE) in a patient with acute coronary syndromes (ACS) wherein the amount of vitronectin receptor gene products is determined in a sample from a patient with acute coronary syndromes and wherein the kit comprises a substance selected from the group of an antibody against sVNR and sVNR.